| #443 |
David Rodriguez-Larrea |
Oxford University |
2 |
| #443 |
Jonathan Edward McKendry |
Oxford Nanopore Technologies Plc |
2 |
| #443 |
André Filipe Marques da Silva |
Sharp Kabushiki Kaisha |
2 |
| #443 |
Christopher Clarke |
ExxonMobil |
2 |
| #443 |
Joshua Charles Treacher |
Faradion Limited |
2 |
| #443 |
Adrien Bizeray |
Oxford University |
2 |
| #443 |
Benjamin LANGLEY |
Oxford Photovoltaics Limited |
2 |
| #443 |
Daniel Crown |
— |
2 |
| #443 |
Pierre-Jean ALET |
CNRS |
2 |
| #443 |
Elizabeth TUNNICLIFFE |
Oxford University |
2 |
| #443 |
Rupert Wilkinson |
— |
2 |
| #443 |
Amir Feizpour |
Oxford University |
2 |
| #443 |
James Paul Sobol |
— |
2 |
| #443 |
Tom Coulter |
— |
2 |
| #443 |
Abhijeet K. Chaudhari |
Samsung |
2 |
| #443 |
Jin-Chong Tan |
Samsung |
2 |
| #443 |
Osnat Hakimi |
Oxford University |
2 |
| #443 |
Abdul Sami Mughal |
Adaptix |
2 |
| #443 |
Vitaliy Babenko |
Oxford University |
2 |
| #443 |
Mattia Signoretto |
Sharp Kabushiki Kaisha |
2 |
| #443 |
Nasim Zargar Baboldashti |
Oxford University |
2 |
| #443 |
Carole Bataille |
Oxford University |
2 |
| #443 |
Anne-Kathrin KIENZLER |
Erasmus University Medical Center Rotterdam |
2 |
| #443 |
Callum Davies |
Owen Mumford Limited |
2 |
| #443 |
Robin Patrick Choudhury |
Oxford University |
2 |
| #443 |
Sridhar Vasudevan |
Isis Innovation Limited |
2 |
| #443 |
Anthony Vivian Langtry |
Tokamak Energy |
2 |
| #443 |
Parshia Moghadas |
Owen Mumford Limited |
2 |
| #443 |
PABITRA KUMAR NAYAK |
Oxford University |
2 |
| #443 |
Michele Taroni |
Roxar Software Solutions As |
2 |
| #443 |
Weiheng Su |
Oxford Genetics |
2 |
| #443 |
Lucy Dorrell |
Oxford University |
2 |
| #443 |
David R. Matthews |
Novartis Ag |
2 |
| #443 |
Peter Norreys |
Oxford University |
2 |
| #443 |
Jane A Endicott |
Cancer Research Campaign Technology Limited |
2 |
| #443 |
Stuart Pace |
ExxonMobil |
2 |
| #443 |
Ervin Fodor |
Mount Sinai School Of Medicine Of New York University |
2 |
| #443 |
Fiza Rashid-Doubell |
Reneuron Limited |
2 |
| #443 |
Helen Katherine Smith |
Aventis Pharmaceuticals |
2 |
| #443 |
Alex Martin Goodall |
Unisys |
2 |
| #443 |
Su Qing Zhang |
Nokia |
2 |
| #443 |
Christopher Mark Cirel |
GE |
2 |
| #443 |
Su Xiangdong |
Sterix Limited |
2 |
| #443 |
John Kroll |
Health Protection Agency |
2 |
| #443 |
Cheng Tsien Chou |
Oxford Instruments Analytical Limited |
2 |
| #443 |
Paul Langford |
Health Protection Agency |
2 |
| #443 |
Rory Warner |
GE |
2 |
| #443 |
David Stuart |
Micropharm Limited |
2 |
| #443 |
Darren Paul Nickerson |
Bg Plc |
2 |
| #443 |
Karim Awenat |
Isis Innovation Limited |
2 |